Simethicone 180 Capsule, Liquid Filled
NDC Package 14803-910-00

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is an UNFINISHED DRUG part of the official NDC directory. Unfinished drugs include products like active ingredients some of which are used in bulk for further processing or compounding. The FDA requires a list of these drugs manufactured in a U.S. commercial distribution facility.

Simethicone 180 capsules is a human otc drug. This formulation utilizes a capsule, liquid filled delivery system. Marketed by Elysium Pharmaceuticals Ltd., this product is identified by NDC 14803-910.

Identification & Billing

NDC Package Code
14803-910-00
Package Description
72000 CAPSULE, LIQUID FILLED in 1 BOX
Product Code
14803-910
11-Digit Billing Format
14803091000

Clinical Specifications

Proprietary Name
Simethicone 180
Non-Proprietary Name
Simethicone 180
Substance Name
Dimethiconol/trimethylsiloxysilicate Crosspolymer (40/60 W/w; 1000000 Pa.s)
Dosage Form
Capsule, Liquid Filled - A solid dosage form in which the drug is enclosed within a soluble, gelatin shell which is plasticized by the addition of a polyol, such as sorbitol or glycerin, and is therefore of a somewhat thicker consistency than that of a hard shell capsule; typically, the active ingredients are dissolved or suspended in a liquid vehicle.
Active Ingredient(s)

Regulatory & Marketing

Labeler Name
Elysium Pharmaceuticals Ltd.
Product Type
Human Otc Drug
Marketing Category
DRUG FOR FURTHER PROCESSING - A drug (other than the bulk ingredient API) that is in an interim stage of manufacture, processing, preparation, or packaging, and not ready for human or animal use.
Start Marketing Date
03-01-2025
Listing Expiration
12-31-2027
Exclude Flag
N
Unfinished Product
Yes
Sample Package
N/A

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 14803-910-00 identifies a specific commercial package of 72000 capsule, liquid filled in 1 box of Simethicone 180 (UNFINISHED drug), a human over the counter drug labeled by Elysium Pharmaceuticals Ltd.. This capsule, liquid filled is formulated for use and contains dimethiconol/trimethylsiloxysilicate crosspolymer (40/60 w/w; 1000000 pa.s) as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Elysium Pharmaceuticals Ltd. on March 01, 2025. The current certification is valid through December 31, 2027.

How is this Elysium Pharmaceuticals Ltd. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 14803091000. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
14803-910-00
11-Digit CMS (5-4-2)
14803-0910-00

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.